Cardiac pacemaker with drug delivery function
Patent Information
- Application Number
- CN202410994860.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-24
- Publication Date
- 2024-11-12
AI Technical Summary
Separate implantation of existing pacemakers and infusion ports increases patient inconvenience and venous vascular blockage rate, and ipsilateral placement increases venous vascular blockage rate and product displacement risk.
Design a pacemaker with drug delivery function, connects the pacemaker with the infusion port through an integrated structure, and uses a dual-cavity central venous catheter and top cover interface system to achieve removable integration, reducing the number of surgeries and Reduce the rate of venous blood vessel blockage.
It significantly reduces the rate of blockage of venous blood vessels, reduces the inconvenience and pain of the patients, and avoids the relative displacement and frictional interference between the electrode leads and the central venous catheter, reducing the cross-sectional area.
Smart Images

Figure CN118925066A_ABST
Abstract
Description
Technical Field
[0001] The present invention is applied in the background of medical technology and is named as a cardiac pacemaker with drug delivery function. Background Art
[0002] As the population ages, the number of patients with pacemaker implants is growing rapidly. According to relevant market research reports, the number of pacemaker implants worldwide is expected to increase from 1.3 million in 2021 to 1.7 million in 2030, with a compound annual growth rate of 3.0%. Most of these pacemaker implant patients are older, and the incidence of tumors also increases with age, according to the assessment of the World Health Organization's International Agency for Research on Cancer (IARC). Therefore, many tumor patients have already had pacemakers implanted.
[0003] For cancer patients who have already had a pacemaker implanted, the current clinical practice is to implant an infusion port on the side opposite to the pacemaker. This can effectively reduce the blockage rate of the intrathoracic veins, but it is necessary to make implantation bags for the pacemaker and the infusion port on both sides of the patient's chest wall, which increases the inconvenience and pain of the patients. There are also a small number of patients who have the pacemaker and infusion port implanted on the same side, but this increases the blockage rate of the veins and the risk of product displacement.
[0004] A cardiac pacemaker with drug delivery function is now proposed, which integrates the cardiac pacemaker and the infusion port into one through a special structure to solve the inconvenience and high venous blockage rate mentioned above. Summary of the invention
[0005] The object of the present invention is to provide a cardiac pacemaker with drug delivery function to solve the problems raised in the above-mentioned background technology.
[0006] In order to solve the above technical problems, the present invention provides the following technical solutions: a cardiac pacemaker with a drug delivery function, comprising a base and an upper shell, wherein the seam between the base and the upper shell is formed into a closed cavity by laser welding, a heat-insulating metal belt is pre-welded on the side of the base seam close to the closed cavity, a top cover interface system is provided on one side of the base, and the base, the upper shell and the top cover interface system together constitute the overall appearance of the novel cardiac pacemaker device.
[0007] In one embodiment, a double-lumen central venous catheter is led out from the end of the top cover interface system, the proximal end of the double-lumen central venous catheter is a double-lumen section, and the double-lumen section is divided into an inner lumen and an outer lumen. The double-lumen central venous catheter and the top cover interface system are connected by a metal connecting shaft, the proximal end of the metal connecting shaft is connected to the inner lumen of the infusion port, and the single-lumen section is coated with a metal coil on the outside.
[0008] In one embodiment, the distal end of the metal connecting shaft is connected to the single-lumen section, the proximal end of the electrode lead needle is connected to the board card, the distal end of the electrode lead needle is connected to the metal sleeve, the double-lumen central venous catheter cavity contains the metal connecting shaft and the electrode lead needle, the top cover interface system separates and solidifies the metal connecting shaft and the electrode lead needle, and the outside of the electrode lead needle is coated with an electrode.
[0009] In one embodiment, area A is provided in the closed cavity formed by the base and the upper shell, a chip is provided at the right end of area A, a board is provided at the upper end of area A, a communication coil is provided at the lower end of the chip, and a battery is provided at the left end of area A.
[0010] In one embodiment, a B zone is provided in the closed cavity formed by the base and the upper shell, a step is provided inside the B zone, a silicone diaphragm is provided on the upper part of the step, an infusion port cavity is provided on the lower part of the step, and a circular hole is opened at the center of the B zone.
[0011] In one embodiment, a separation zone is provided between the area A and the area B, a circular groove is provided on the top surface of the separation zone, and sealing silicone is provided in the groove of the circular groove.
[0012] Compared with the prior art, the beneficial effects achieved by the present invention are as follows: the present invention connects the pacemaker and the infusion port together in a detachable manner to form a pacemaker that can deliver medication. This novel pacemaker device can reduce the number of surgeries for the patient when it is placed in the patient, avoids the relative displacement and friction interference caused by the coexistence of the electrode wire and the central venous catheter, significantly reduces the cross-sectional area when the two exist at the same time, alleviates the inconvenience and pain of the patient, and reduces the overall venous blockage rate. BRIEF DESCRIPTION OF THE DRAWINGS
[0013] The technical solution and other beneficial effects of the present application will be made apparent by describing in detail the specific implementation methods of the present application in conjunction with the accompanying drawings.
[0014] In the attached picture:
[0015] Figure 1 It is a schematic diagram of the overall structure of the present invention;
[0016] Figure 2 is a top view of the base of the present invention;
[0017] Figure 3 is a cross-sectional view of the inner cavity of zone B of the present invention;
[0018] Figure 4 is a top view of the top cover interface system and the double-lumen central venous catheter of the present invention;
[0019] Figure 5 is a cross-sectional view of a double-lumen central venous catheter of the present invention;
[0020] Figure 6 It is a bottom view of the upper shell of the present invention;
[0021] In the figure: 2, double-lumen central venous catheter; 11, base; 12, upper shell; 13, top cover interface system; 111, area A; 112, area B; 113, separation belt; 1111, chip; 1112, board; 1113, communication coil; 1114, battery; 1121, step; 1122, silicone diaphragm; 1123, inner cavity of infusion port; 1131, annular groove; 1132, sealing silicone; 114, insulating metal belt; 21, double-lumen section; 211, inner cavity; 212, outer cavity; 22, single-lumen section; 2131, metal sleeve; 2132, electrode; 131, metal connecting shaft; 132, electrode lead needle; 1221, round hole. DETAILED DESCRIPTION
[0022] The disclosure below provides many different embodiments or examples to realize the different structures of the present application. In order to simplify the disclosure of the present application, the parts and settings of specific examples are described below. Of course, they are only examples, and the purpose is not to limit the present application. In addition, the present application can repeat reference numbers and / or reference letters in different examples, and this repetition is for the purpose of simplification and clarity, which itself does not indicate the relationship between the various embodiments and / or settings discussed. In addition, the various specific processes and material examples provided by the present application, but those of ordinary skill in the art can appreciate the application of other processes and / or the use of other materials.
[0023] See also Figure 1-5 The present invention provides a technical solution: a cardiac pacemaker with drug delivery function, comprising a base 11 and an upper shell 12, the base 11 and the upper shell 12 are snap-connected to form a closed cavity, a heat-insulating metal belt 114 is pre-welded on the side of the base 11 joint close to the closed cavity, the heat-insulating metal belt 114 protects the interior of the novel cardiac pacemaker device from high temperature during the laser welding process, a top cover interface system 13 is provided on one side of the base 11, the base 11, the upper shell 12 and the top cover interface system 13 together constitute the overall appearance of the novel cardiac pacemaker device, the device integrates the infusion port and the pacemaker in a detachable manner, effectively reduces the area of the two in the patient's body and reduces the number of surgeries for the patient, thereby alleviating the pain for the patient;
[0024] The top cover interface system 13 is injection molded by polymer materials such as epoxy resin, silicone, polycarbonate, etc. The end of the top cover interface system 13 leads to the double-lumen central venous catheter 2. The proximal end of the double-lumen central venous catheter 2 is a double-lumen section 21. The double-lumen section 21 is divided into an inner cavity 211 and an outer cavity 212. The diameter of the inner cavity 211 is between 1 and 3F, and the outer cavity 212 is a cavity for delivering chemotherapy liquid to the distal end of the double-lumen central venous catheter 2. The outer diameter of the double-lumen section 21 is the same as that of the double-lumen central venous catheter 2 equipped with an existing infusion port. The double-lumen central venous catheter 2 is the same as or slightly larger than the double-lumen central venous catheter 2. The distal end of the double-lumen central venous catheter 2 is a single-lumen section 22. The single-lumen section 22 has only an inner lumen 211 with an outer diameter of 2 to 4F. The double-lumen structure of the catheter is 15 to 55 cm long, and the single-lumen section 22 is 5 to 15 cm long to meet the needs of different patients. The setting of the double-lumen central venous catheter 2 avoids the relative displacement and friction interference caused by the coexistence of the electrode wire and the central venous catheter in the existing treatment plan, significantly reduces the cross-sectional area when the two coexist, and reduces the incidence of venous thrombosis.
[0025] The double-lumen central venous catheter 2 and the top cover interface system 13 are connected by a metal connecting shaft 131. The proximal end of the metal connecting shaft 131 is connected to the inner cavity 1123 of the infusion port, and the distal end of the metal connecting shaft 131 is connected to the single-lumen section 22. The proximal end of the electrode lead needle 132 is connected to the board card 1112, and the distal end of the electrode lead needle 132 is connected to the metal sleeve 2131. Through this connection method, the wire of the electrode 2132 is connected to the A area 111 in the device, and the outer cavity 212 of the double-lumen central venous catheter 2 is connected to the B area 112, forming a special structure.
[0026] The double-lumen central venous catheter 2 contains a metal connecting shaft 131 and an electrode lead needle 132 in the lumen. The top cover interface system 13 separates and solidifies the metal connecting shaft 131 and the electrode lead needle 132. The electrode lead needle 132 is coated with an electrode 2132 on the outside. The outer diameter of the metal connecting shaft 131 is 6.5F to 9F, and the inner diameter is 5.5F to 8F. The electrode 2132 directly contacts the heart tissue and is used to detect the heart's electrical signals and transmit pacing signals.
[0027] A region A 111 is arranged in a closed cavity formed by the base 11 and the upper shell 12, a chip 1111 is arranged at the right end of the region A 111, a board 1112 is arranged at the upper end of the region A 111, a communication coil 1113 is arranged at the lower end of the chip 1111, a battery 1114 is arranged at the left end of the region A 111, a separation belt 113 is arranged between the region A 111 and the region B 112, a circular groove 1131 is arranged on the top surface of the separation belt 113, a sealing silica gel 1132 is arranged in the groove of the circular groove 1131, the sealing silica gel 1132 can prevent the drug solution from leaking into the region A 111 when the patient is infused, thereby affecting the use effect of the region A 111, and an antibacterial cover is arranged on the outer side of the sealing silica gel 1132, which can reduce the incidence of pacemaker infection caused by the maintenance and replacement of the infusion port needle;
[0028] A B area 112 is arranged in the sealed cavity formed by the base 11 and the upper shell 12, a step 1121 is arranged inside the B area 112, a silicone diaphragm 1122 is arranged on the upper part of the step 1121, and an infusion port cavity 1123 is arranged on the lower part of the step 1121. A circular hole 1221 is opened at the center of the B area 112, and the inner diameter of the circular hole 1221 is smaller than the outer diameter of the silicone diaphragm 1122, so as to facilitate the fixing of the silicone diaphragm 1122. The silicone diaphragm 1122 is a silicone layer with a thickness of two centimeters, which can withstand 2000 or more punctures. When the infusion port needs to be replaced, the infusion port can be removed from the base 11 by opening the upper shell 12;
[0029] Working principle:
[0030] The present invention designs a cardiac pacemaker device capable of drug administration through an integrated special structure, and designs a dual-lumen central venous catheter 2 matching the novel cardiac pacemaker device, thus forming a novel pacemaker device having both long-term central venous drug administration and cardiac pacing functions.
[0031] The sealed cavity formed by laser welding of the base 11 and the upper shell 12 divides the device into area A 111 and area B 112 through a dividing strip 113. Area A 111 corresponds to the cardiac pacing function module, and area B 112 corresponds to the drug infusion module. Sealing silicone 1132 is provided on the top of the dividing strip 113 to prevent area A 111 and area B 112 from affecting each other. Arranging these two devices together reduces the area of the pacemaker and the infusion port in the patient's body at the same time, reduces the number of operations, and relieves the pain for the patient.
[0032] The double-lumen central venous catheter 2 is divided into an inner lumen 211 and an outer lumen 212. The inner lumen 211 of the double-lumen central venous catheter 2 is used to cover the wire of the electrode 2132, and the outer lumen 212 is used for drug infusion. The wire of the electrode 2132 in the double-lumen central venous catheter 2 is connected to the A area 111 in the device through the electrode lead 132 in the top cover interface system 13 on the top of the new cardiac pacemaker device, and the outer lumen 212 in the catheter is connected to the B area 112 in the device through the metal connecting shaft 131 in the interface system. The design of the double-lumen central venous catheter 2 avoids the relative displacement and friction interference caused by the simultaneous existence of the electrode wire and the central venous catheter in the existing treatment plan, significantly reduces the cross-sectional area when the two exist at the same time, and reduces the incidence of venous thrombosis.
[0033] In the description of this application, it should be noted that, unless otherwise clearly specified and limited, the terms "installed", "connected", and "connected" should be understood in a broad sense, for example, it can be a fixed connection, a detachable connection, or an integral connection; it can be a mechanical connection, an electrical connection, or mutual communication; it can be a direct connection, internal communication between two elements, or an interaction relationship between two elements. For ordinary technicians in this field, the meanings of the above terms in this application can be understood according to specific circumstances.
[0034] The above is a detailed introduction to a cardiac pacemaker with a drug delivery function provided in an embodiment of the present application. Specific examples are used herein to illustrate the principles and implementation methods of the present application. The description of the above embodiments is only used to help understand the technical solutions and core ideas of the present application. Ordinary technicians in this field should understand that they can still modify the technical solutions recorded in the aforementioned embodiments, or replace some of the technical features therein with equivalents. However, these modifications or replacements do not cause the essence of the corresponding technical solutions to deviate from the scope of the technical solutions of the embodiments of the present application.
Claims
1. A cardiac pacemaker with drug delivery function, comprising a base (11) and an upper shell (12), Features: The seam between the base (11) and the upper shell (12) is formed into a sealed cavity by laser welding, a heat-insulating metal belt (114) is pre-welded on the side of the base (11) seam close to the sealed cavity, a top cover interface system (13) is provided on one side of the base (11), and the base (11), the upper shell (12) and the top cover interface system (13) together constitute the overall appearance of the novel cardiac pacemaker device.
2. A cardiac pacemaker with drug delivery function according to claim 1, Features: A double-lumen central venous catheter (2) is led out from the end of the top cover interface system (13), and the proximal end of the double-lumen central venous catheter (2) is a double-lumen section (21), and the double-lumen section (21) is divided into an inner lumen (211) and an outer lumen (212).
3. A cardiac pacemaker with drug delivery function according to claim 2, Features: The double-lumen central venous catheter (2) and the top cover interface system (13) are connected via a metal connecting shaft (131), and the proximal end of the metal connecting shaft (131) is connected to and passes through the inner cavity (1123) of the infusion port.
4. A cardiac pacemaker with drug delivery function according to claim 3, Features: The distal end of the metal connecting shaft (131) is connected to the single-lumen section (22), the proximal end of the electrode lead needle (132) is connected to the board card (1112), the distal end of the electrode lead needle (132) is connected to the metal shaft sleeve (2131), and the single-lumen section (22) is externally coated with a metal coil (213).
5. A cardiac pacemaker with drug delivery function according to claim 4, Features: The double-lumen central venous catheter (2) contains a metal connecting shaft (131) and an electrode lead needle (132) in the lumen, the top cover interface system (13) separates and solidifies the metal connecting shaft (131) and the electrode lead needle (132), and the outer side of the electrode lead needle (132) is coated with an electrode (2132).
6. A cardiac pacemaker with drug delivery function according to claim 5, Features: An A zone (111) is arranged in a sealed cavity formed by the base (11) and the upper shell (12); a chip (1111) is arranged at the right end of the A zone (111); a board (1112) is arranged at the upper end of the A zone (111); a communication coil (1113) is arranged at the lower end of the chip (1111); and a battery (1114) is arranged at the left end of the A zone (111).
7. A cardiac pacemaker with drug delivery function according to claim 6, Features: A B zone (112) is arranged in a closed cavity formed by the base (11) and the upper shell (12); a step (1121) is arranged inside the B zone (112); a silicone diaphragm (1122) is arranged on the upper part of the step (1121); an infusion port cavity (1123) is arranged on the lower part of the step (1121); and a circular hole (1221) is opened at the center of the B zone (112).
8. A cardiac pacemaker with drug delivery function according to claim 7, Features: A separation zone (113) is provided between the A zone (111) and the B zone (112), a circular groove (1131) is provided on the top surface of the separation zone (113), and a sealing silicone rubber (1132) is provided in the groove of the circular groove (1131).
